VineethSukrithanMD

PubMed

• 1 citations
  A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
  Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg, Timothy J Hobday, Thomas Semrad, Diane Reidy-Lagunes, Hedy Lee Kindler, George P Kim, J...> ;Endocrine-Related Cancer. 2023 Nov 1
• 3 citations
  Clinical Outcomes of DEB-TACE in Hepatic Metastatic Neuroendocrine Tumors: A 5-Year Single-Institutional Experience.
  Mina S Makary, Luis E Regalado, Jonathan Alexander, Vineeth Sukrithan, Bhavana Konda, Jordan M Cloyd> ;Academic Radiology. 2023 Sep 1
• Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib.
  Vineeth Sukrithan, Lisa Kim, Jennifer A Sipos, Ashima Goyal, Ye Zhou, Daniel Addison, Manisha Shah, Bhavana Konda, Ajay Vallakati> ;Case Reports in Endocrinology. 2023 Jan 1
• 1 citations
  Kinase inhibitors in thyroid cancers.
  Vineeth Sukrithan, Prachi Jain, Manisha H Shah, Bhavana Konda> ;Endocrine Oncology. 2023 Jan 1
• 10 citations
  A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms.
  Dwight H Owen, Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou, Carly Pilcher, Sheryl-Ann Suffren, Gwen Christenson, Nancy Curtis, Megan Jukich, Emily...> ;Clinical Cancer Research. 2023 Feb 16
• 11 citations
  An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma.
  Alycia Hatashima, Brianna Archambeau, Heather Armbruster, Menglin Xu, Manisha Shah, Bhavana Konda, Abberly Lott Limbach, Vineeth Sukrithan> ;Thyroid. 2022 Aug 1
• Emerging drugs for the treatment of adrenocortical carcinoma.
  Vineeth Sukrithan, Marium Husain, Lawrence S. Kirschner, Manisha H. Shah, Bhavana Konda> ;Expert Opinion on Emerging Drugs. 2021 May 3
• 4 citations
  Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.
  Fadi Nabhan, Elizabeth Kander, Rulong Shen, Amit Agrawal, Vineeth Sukrithan, Ye Zhou, Ashima Goyal, Katie Roll, Manisha H. Shah, Bhavana Konda> ;Case Reports in Endocrinology. 2021 Jan 1
• Implementation of a Low-Cost Quality Improvement Intervention Increases Adherence to Cancer Screening Guidelines and Reduces Healthcare Costs at a University Medical C...
  Alejandro Recio-Boiles, Michael Karass, Jose Nahun Galeas, Vineeth Sukrithan, Andrew H Gutwein, Hani M. Babiker> ;Journal of Cancer Education. 2020 Oct 1
• 16 citations
  Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung Cancer.
  Hongling Zhao, Niloy J. Iqbal, Vineeth Sukrithan, Cari Nicholas, Yingjiao Xue, Cindy Yu, Joseph Locker, Juntao Zou, Edward L. Schwartz, Liang Zhu> ;Cancer Research. 2020 Jun 1
• Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer.
  Vineeth Sukrithan, Alexander Barbaro, Adel Chergui, Brian Ko, Juan Lin, Haiying Cheng, Sanjay Goel> ;American Journal of Clinical Oncology. 2020 Jan 1
• 21 citations
  Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma.
  Vineeth Sukrithan, Jason E. Sandler, Rasim Gucalp, Richard J. Gralla, Balazs Halmos> ;Clinical Lung Cancer. 2019 May 1
• 11 citations
  Emerging drugs for EGFR-mutated non-small cell lung cancer
  Vineeth Sukrithan, Lei Deng, Alexander Barbaro, Haiying Cheng> ;Expert Opinion on Emerging Drugs. 2019 Jan 2
• 1 citations
  Sequencing therapies in oncogene-driven non-small-cell lung cancer: how to get the best mileage?
  Vineeth Sukrithan, Rose Snyder, Haiying Cheng, Balazs Halmos> ;Future Oncology. 2019 Aug 19
• 55 citations
  Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation
  Tushar D. Bhagat, Si Chen, Matthias Bartenstein, A. Trevor Barlowe, Dagny Von Ahrens, Gaurav Choudhary, Patrick Tivnan, Elianna M. Amin, A. Mario Marcondes, Mathijs A....> ;Cancer Research. 2017 Sep 15
• 2 citations
  Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two Cases.
  Dimpi Desai, Devika Rao, Vineeth Sukrithan, Eleanor Weinstein, Akankasha Goyal, Ulrich K. Schubart> ;Journal of Investigative Medicine High Impact Case Reports. 2017 Jun 8
• 26 citations
  A systematic review finds limited data on measurement properties of instruments measuring outcomes in adult intensive care unit survivors.
  Karen A. Robinson, Wesley E. Davis, Victor D. Dinglas, Pedro A. Mendez-Tellez, Anahita Rabiee, Vineeth Sukrithan, Ramakrishna Yalamanchilli, Alison E. Turnbull, Dale M...> ;Journal of Clinical Epidemiology. 2017 Feb 1
• 28 citations
  Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia
  Lohith S. Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris, Matthias Bartenstein, Nandini Ramachandra, Orsolya Giricz, Vineeth Sukrithan, George Nwankwo...> ;Cancer Research. 2016 Aug 15
• 4 citations
  Systemic mastocytosis presenting as cardiac tamponade with CD25(+) pericardial mast cells.
  Vineeth Sukrithan, Jason N. Salamon, Giorgi Berulava, Nicholas E.S. Sibinga, Amit Verma> ;Clinical Case Reports. 2016 Feb 8
• 104 citations
  Updated systematic review identifies substantial number of retention strategies: Using more strategies retains more study participants
  Karen A. Robinson, Victor D. Dinglas, Vineeth Sukrithan, Ramakrishna Yalamanchilli, Pedro A. Mendez-Tellez, Cheryl Dennison-Himmelfarb, Dale M. Needham> ;Journal of Clinical Epidemiology. 2015 Dec 1
• Join now to see all